Comparison of perioperative blood loss and transfusion rate in primary unilateral total hip arthroplasty by topical, intravenous application or combined application of tranexamic acid

doi:10.3969/j.issn.2095-4344.2016.04.001

Chinese Journal of Tissue Engineering Research ›› 2016, Vol. 20 ›› Issue (4): 459-463.doi: 10.3969/j.issn.2095-4344.2016.04.001

Comparison of perioperative blood loss and transfusion rate in primary unilateral total hip arthroplasty by topical, intravenous application or combined application of tranexamic acid

Zhao Qing-bin, Ren Jiang-dong, Zhang Xiao-gang, Wu Hu-zi•Wu Lamu

Department of Joint Surgery, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China

Received:2015-11-30 Online:2016-01-22 Published:2016-01-22
Contact: Zhang Xiao-gang, Associate professor, Chief physician, Master’s supervisor, Department of Joint Surgery, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
About author:Zhao Qing-bin, Department of Joint Surgery, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
Supported by:
the Science and Technology Project of Xinjiang Uygur Autonomous Region, No. 201332106

Abstract

Abstract:

BACKGROUND: The tranexamic acid has been widely used in hip arthroplasty. Studies have confirmed that the safety and efficacy of tranexamic acid when it is used in topical or intravenous application, but the effects are not clear when it is used in both topical and intravenous application.
OBJECTIVE: To compare perioperative blood loss and transfusion rate in primary unilateral total hip arthroplasty with topical, intravenous and both injection of tranexamic acid.
METHODS: 136 patients undergoing primary unilateral total hip arthroplasty in the First Affiliated Hospital, Xinjiang Medical University between July 2014 and June 2015 were divided into three groups. Topical group: a total of 1 g tranexamic acid was given in the articular cavity of 44 cases. Intravenous group: 1 g tranexamic acid was immersed in 250 mL physiological saline, and given 10 minutes before operation in 44 cases. Combined group: 1 g tranexamic acid was intravenously given before operation, and then given in the articular cavity in 48 cases. Total blood loss, transfusion rate, the maximum hemoglobin decrease, the maximum hematocrit decrease, and incidence of deep vein thrombosis were compared among the three groups.
RESULTS AND CONCLUSION: Total blood loss, the maximum hemoglobin decrease and the maximum hematocrit decrease were significantly lower in the combined group than in the topical group and intravenous group (P < 0.01). No significant difference in total blood loss, the maximum hemoglobin decrease and the maximum hematocrit decrease was detected between the topical group and intravenous group (P > 0.05). Doppler ultrasound examination of lower limb blood vessel at 5 days and 1 month after surgery in 136 patients did not demonstrate deep vein thrombosis. None of them suffered from pulmonary embolism. These findings confirm that intravenous and topical application of tranexamic acid could obviously reduce blood loss in patients with total hip arthroplasty. Curative effect and safety were superior to intravenous or topical application alone. No significant difference in transfusion rate was detected among the three methods.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

Zhao Qing-bin, Ren Jiang-dong, Zhang Xiao-gang, Wu Hu-zi•Wu Lamu. Comparison of perioperative blood loss and transfusion rate in primary unilateral total hip arthroplasty by topical, intravenous application or combined application of tranexamic acid[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(4): 459-463.

Figures/Tables 3

References

[1] Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am. 1996;78(8):1260-1270.
[2] Triulzi DJ, Vanek K, Ryan DH, et al. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion. 1992; 32(6):517-524.
[3] Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009;113(15):3406-3417.
[4] Paul JE, Ling E, Lalonde C, et al. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth. 2007;54(10):799-810.
[5] Niemi TT, Pitkanen M, Syrjala M, et al. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand. 2000;44(4):457-464.
[6] Hawi N, Kendoff DO, Hessling U, et al. Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty. Int Orthop. 2014;38(8):1603-1608.
[7] Horstmann WG, Swierstra MJ, Ohanis D, et al. Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. Int Orthop. 2014;38(1):13-18.
[8] Rajesparan K, Biant LC, Ahmad M, et al. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg (Br). 2009;91(6): 776-783.
[9] Kazemi SM, Mosaffa F, Eajazi A, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics. 2010;33(1):17.
[10] Singh J, Ballal MS, Mitchell P, et al. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg (Hong Kong). 2010;18(3):282-286.
[11] Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg. 2007;107(4):397.
[12] Sukeik M, Alshryda S, Haddad FS, et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011;93(1):39-46.
[13] Imai N, Dohmae Y, Suda K, et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty. 2012;27(10):1838-1843.
[14] Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005;76(3):314-319.
[15] Noordin S, Waters TS, Garbuz DS, et al. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res. 2011;469(2):541-546.
[16] Alshryda S, Mason J, Sarda P, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am. 2013;95(21): 1969-1974.
[17] Konig G, Hamlin BR, Waters JH. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty. 2013;28(9):1473.
[18] Yue C, Kang P, Pei F et al. Topical application of tranexamic acid in primary total hiparthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014;29(12):2452-2456.
[19] Sattar S, Mason J, Sarda P, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am. 2013;95(21): 1969-1974.
[20] Martin JG, Cassatt KB, Kincaid-Cinnamon KA, et al. Topical administration of tranexamic Acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014;29(5):889-894.
[21] 邱贵兴.中国骨科大手术静脉血栓栓塞症预防指南[J].中华关节外科杂志:电子版,2009,3(3):380-383.
[22] 岳辰,谢锦伟,裴福兴,等.静脉联合局部应用氨甲环酸减少初次全髋关节置换围置换期失血的有效性及安全性研究[J].中华骨与关节外科杂志,2015,8(1):44-48.
[23] Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224-232.
[24] Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty. Jarthroplasty. 2011;26(7):1100-1105.
[25] Price AJ. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am. 1982;64(8):1260.
[26] Kazemi SM, Mosaffa F, Eajazi A, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics. 2010;33(1):17.
[27] Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol). 1980;14:35.
[28] Mannucci PM. Hemostatic drugs. N Engl J Med. 1998; 339(4): 245-253.
[29] Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387-389.
[30] Wei W, Wei BF. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthrop. 2014;29(11):2113-2116.

Comparison of perioperative blood loss and transfusion rate in primary unilateral total hip arthroplasty by topical, intravenous application or combined application of tranexamic acid

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References

Related Articles 0

Recommended Articles

Metrics

Comments